Oncomedics presents a selection of reference publications related to the technologies and approaches developed by OncoMedics, including ex vivo chemosensitivity tests, ATP-based assays, organoids, and predictive models for individualized chemotherapy in oncology, particularly in colorectal cancer and peritoneal metastases.
Oncomedics reference publications
Oncomedics Reference Publications
Selected Publications
Ann Surg Treat Res. 2019 Aug;97(2):93-102.
SLAS Technol. 2017 Jun;22(3):306-314.
Int J Pharm. 2017 Oct 5;531(1):143-152.
Anticancer Research. 2017 Mar;37(3):1297-1303.
Anticancer Res. 2017 May;37(5):2679-2682.
Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy
J Lab Autom. 2016 Feb;21(1):178-87. [PDF]
Cancer Res Treat. 2016 Jul;48(3):970-7.
Precision medicine for cancer with next-generation functional diagnostics
Nat Rev Cancer. 2015 Dec;15(12):747-56. [PDF]
Role of Conventional Chemosensitivity Test and Tissue Biomarker Expression in Predicting Response to Treatment of Peritoneal Carcinomatosis From Colon Cancer
Clinical Colorectal Cancer. 2013 Jun;12(2):122-127. [PDF]
Clinical potential of the anticancer drug sensitivity test for patients with synchronous stage IV colorectal cancer
Cancer Chemother Pharmacol. 2013;72:217-222. [PDF]
Applicability of Histoculture Drug Response Assays in Colorectal Cancer Chemotherapy
Anticancer Res. 2012 Aug;32(8):3581-6. [PDF]
Interested in Oncomedics Technologies?
Contact us for more information on ex vivo chemosensitivity tests, predictive assays, or to discuss clinical and preclinical applications.
Contact us at tech@oncomedics.com
Contact Us